SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-065324
Filing Date
2024-05-28
Accepted
2024-05-28 07:36:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2415611d2_defa14a.htm DEFA14A 19340
2 GRAPHIC tm2415611d2_defa14aimg001.jpg GRAPHIC 17242
  Complete submission text file 0001104659-24-065324.txt   44410
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

IRS No.: 934958665 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41740 | Film No.: 24986286
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)